Studies in health technology and informatics
Apr 24, 2025
BACKGROUND: Type 2 diabetes (T2D) continues to present a global public health challenge due to its increasing prevalence. Early diagnosis is critical for preventing complications, but current screening methods often fail to detect early diabetic cond...
Previous research has established type 2 diabetes mellitus as a significant risk factor for various disorders, adversely impacting human health. While evidence increasingly links type 2 diabetes to cognitive impairment and brain disorders, understand...
Diabetes mellitus is a complex metabolic disorder and one of the fastest-growing global public health concerns. The gut microbiota is implicated in the pathophysiology of various diseases, including diabetes. This study utilized 16S rRNA metagenomic ...
Studies in health technology and informatics
Feb 18, 2025
The increasing prevalence of preventable chronic disease in Canada poses significant challenges to both healthcare budgets and individual financial stability. New treatments and predictive technologies are creating an urgent need to evaluate the impa...
There is mounting interest in the possibility that metformin, indicated for glycemic control in type 2 diabetes, has a range of additional beneficial effects. Randomized trials have shown that metformin prevents adverse cardiovascular events, and met...
SUMMARY: Polygenic risk scores (PRSs) hold promise for early disease diagnosis and personalized treatment, but their overall discriminative power remains limited for many diseases in the general population. As a result, numerous novel PRS modeling te...
The dose-response relationship between metformin and change in hemoglobin A1c (HbA1c) shows a maximum at 1500-2000 mg/day in patients with type 2 diabetes (T2D) in the U.S. In Japan, there is little evidence on the HbA1c-lowering effect of high-dose ...
Biomedical and environmental sciences : BES
Jan 20, 2025
OBJECTIVE: To establish and validate a novel diabetic retinopathy (DR) risk-prediction model using a whole-exome sequencing (WES)-based machine learning (ML) method.
BACKGROUND/PURPOSE OF THE STUDY: Type 2 diabetes mellitus (T2DM)-one of the fastest globally spreading diseases-is a chronic metabolic disorder characterized by elevated blood glucose levels. It has been suggested that the composition of gut microbio...
BACKGROUND: To establish a classification model for assisting the diagnosis of type 2 diabetes mellitus (T2DM) complicated with coronary heart disease (CHD).
Join thousands of healthcare professionals staying informed about the latest AI breakthroughs in medicine. Get curated insights delivered to your inbox.